iBio, Inc. (IBIO)
NASDAQ: IBIO · Real-Time Price · USD
2.160
-0.040 (-1.82%)
At close: Apr 10, 2026, 4:00 PM EDT
2.195
+0.035 (1.63%)
After-hours: Apr 10, 2026, 6:17 PM EDT
iBio, Inc. Stock Forecast
Stock Price Forecast
The 4 analysts that cover iBio, Inc. stock have a consensus rating of "Strong Buy" and an average price target of $4.75, which forecasts a 119.91% increase in the stock price over the next year. The lowest target is $2.00 and the highest is $7.00.
Price Target: $4.75 (+119.91%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for iBio, Inc. stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 1 | 2 | 2 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 3 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Chardan Capital | Chardan Capital | Strong Buy Maintains $5 | Strong Buy | Maintains | $5 | +131.48% | Apr 9, 2026 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $5 | Strong Buy | Maintains | $5 | +131.48% | Mar 18, 2026 |
| Jones Trading | Jones Trading | Strong Buy Initiates $7 | Strong Buy | Initiates | $7 | +224.07% | Mar 3, 2026 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $5 | Strong Buy | Maintains | $5 | +131.48% | Feb 12, 2026 |
| Oppenheimer | Oppenheimer | Buy Initiates $5 | Buy | Initiates | $5 | +131.48% | Oct 21, 2025 |
Financial Forecast
Revenue This Year
183.60K
from 400.00K
Decreased by -54.10%
Revenue Next Year
102.00K
from 183.60K
Decreased by -44.44%
EPS This Year
-0.32
from -1.75
EPS Next Year
-0.30
from -0.32
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 525,000 | 525,000 | |||
| Avg | 183,600 | 102,000 | |||
| Low | 98,000 | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 31.3% | 185.9% | |||
| Avg | -54.1% | -44.4% | |||
| Low | -75.5% | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | -0.29 | -0.20 | ||
| Avg | -0.32 | -0.30 | ||
| Low | -0.34 | -0.38 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | - | - | ||
| Avg | - | - | ||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.